Sign in to view content

Retinal Nonperfusion and Anti-VEGF Therapy in Diabetic Retinopathy: What We Know and What We Don’t Know

Dante Joseph Pieramici, MD

Video
Published 2017

Related

Amine Oxidase Copper-Containing 3 Inhibitor (BI 1467335) in Non-Proliferative Diabetic Retinopathy: Double-Masked, Randomized, Phase IIa Study (ROBIN)
Quan Dong Nguyen, MD, MSc, FARVO, FASRS
Annual Meeting Talks
2021
Journal Club with Dr. Ferhina Ali and Dr. Daniel Chao Discussing Caffeine and Beta Blockers for Vitreoretinal Surgeons, Cost-Savings with Intravitreal Bevacizumab, and more
Jayanth Sridhar, MD
Daniel L Chao, MD, PhD
Ferhina S Ali, MD, MPH
Member Podcasts
2020
Remarkable Findings From Steroids for DME Studies
Rishi P. Singh, MD
Updates from the Field
2017

Category: Diabetic Retinopathy

See more